Faeth Therapeutics, Inc. (FTH)

NASDAQ: FTH · Real-Time Price · USD

32.34

+3.79 (13.27%)

At close: Aug 14, 2026, 4:00 PM EDT

32.51

+0.16 (0.51%)

After-hours: Aug 14, 2026, 7:34 PM EDT

Faeth Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	26.9	8.67	9.99	13.01	17.8	7.16
Short-Term Investments	159.54	12.52	31.34	52.75	89.32	140.46
Cash & Short-Term Investments	186.44	21.18	41.34	65.76	107.12	147.62
Cash Growth	551.25%	-48.75%	-37.14%	-38.61%	-27.44%	789.50%
Prepaid Expenses	1.36	0.23	0.47	1.17	1.13	0.55
Other Current Assets	0.86	0.09	0.12	0.33	0.34	0.37
Total Current Assets	188.66	21.51	41.93	67.25	108.59	148.54
Property, Plant & Equipment	0.57	1.38	3.38	7.04	9.72	4.64
Other Long-Term Assets	0.08	0.02	0.05	0.09	0.06	0.04
Total Assets	189.31	22.9	45.36	74.37	118.38	153.23

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.15	0.69	0.24	0.57	4.47	2.46
Accrued Expenses	6.67	2.04	2.73	2.41	2.46	1.75
Current Portion of Leases	0.59	1.45	2.32	2.44	2.13	0.68
Other Current Liabilities	0.18	0.08	0.16	0.22	-	-
Total Current Liabilities	9.58	4.25	5.45	5.64	9.07	4.89
Long-Term Leases	-	0.06	1.53	3.77	5.9	1.67
Other Long-Term Liabilities	6.77	-	-	0.07	-	0.15
Total Liabilities	16.35	4.31	6.98	9.48	14.97	6.71

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	-	-	0	0	0
Additional Paid-In Capital	642.4	301.73	300.45	297	302.2	296.05
Retained Earnings	-469.38	-283.14	-262.05	-231.9	-197.79	-149.21
Comprehensive Income & Other	-0.06	0	-0.01	-0.21	-1	-0.33
Total Common Equity	172.96	18.59	38.39	64.9	103.41	146.51
Shareholders' Equity	172.96	18.59	38.39	64.9	103.41	146.51
Total Liabilities & Equity	189.31	22.9	45.36	74.37	118.38	153.23

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.59	1.51	3.85	6.21	8.03	2.35
Net Cash (Debt)	185.85	19.68	37.49	59.55	99.08	145.27
Net Cash Growth	612.91%	-47.52%	-37.04%	-39.90%	-31.79%	813.00%
Net Cash Per Share	78.38	15.61	29.85	42.61	64.54	104.85
Filing Date Shares Outstanding	25.84	1.34	1.26	1.25	1.55	1.53
Total Common Shares Outstanding	25.83	1.26	1.26	1.25	1.54	1.53
Working Capital	179.08	17.26	36.48	61.61	99.52	143.65
Book Value Per Share	6.70	14.74	30.49	51.85	67.23	95.73
Tangible Book Value	172.96	18.59	38.39	64.9	103.41	146.51
Tangible Book Value Per Share	6.70	14.74	30.49	51.85	67.23	95.73
Machinery	0.4	0.37	1.66	2.64	3.24	5.58
Leasehold Improvements	0.25	0.25	0.25	0.25	0.25	0.25

SEC Filings: 10-K · 10-Q